USP 71 Sterility Test

Sterility testing for medical devices, pharmaceutical products, and radiopharmaceuticals, as defined in the "USP 71 Sterility Testing" standard published by the United States Pharmacopeia (USP), is a testing process required for sterilization verification and batch release. These tests are performed in three primary ways for the following applications:

• Membrane filtration, primarily used for pharmaceutical products: The membrane filtration sterility testing method, typically used for filterable pharmaceutical products, uses a 0,45-micron pore-size filter to collect microorganisms from a sample. The filter is then transferred to an aerobic or anaerobic environment, depending on the microbes being tested. The following media are typically used in this method:
  • Liquid thioglycolate medium incubated at 30-35 degrees Celsius. This medium is used for anaerobic microorganisms.
  • Soy-based medium incubated at 20-25 degrees Celsius. This medium is used for aerobic microorganisms, including yeasts and molds.

The media is examined during the 14-day incubation period for signs of microbial growth, including turbidity and pellicle formation. Any contaminants present are then confirmed and identified by agar streaks. As with all testing processes, membrane filtration testing equipment is validated to ensure accurate results. Membrane filtration is the preferred method, particularly for pharmaceutical products containing preservatives or other substances that inhibit microbial growth.

• Direct transfer, primarily used for medical devices: The direct transfer sterility testing method, typically used for medical devices, involves immersing the entire product in the test medium, allowing microorganisms to transfer from the product to the medium. This process is particularly useful in scenarios where a medical product or device may not have been adequately sterilized, resulting in damaged but not destroyed microbes. With the direct transfer method, these microbes can repair themselves and thus be accurately identified.

Direct transfer typically occurs in two types of media. Appropriate processes are followed to aseptically separate the product into two or more aliquots for testing in both types of media. Larger products are also handled, requiring identification, removal, and testing of contact areas. Samples are incubated for 14 days, during which time the media is regularly examined for signs of microbial growth.

• Product Washing Used for Hollow Tube Products: The product washing sterility testing method, typically used for hollow tube products, involves washing the tube and filtering the eluate through a submicron membrane. The sample is then transferred to liquid thioglycolate media and soy-based media for a 14-day incubation period and is examined regularly for microbial growth.

Advanced laboratories adhere to all USP 71 Sterility test qualification guidelines. These include a compliance test, which ensures that microbes, if present, will grow in the test medium, and a verification test, which ensures that the test sample does not inhibit the growth of microbes through inertia. These verification processes are crucial to ensuring that a company's testing processes remain compliant and support its approval and release objectives.

The concept of method suitability testing is simple. A small number of microbes are added to the product, the product is filtered, and then placed on the filter medium. The product can also be inoculated directly into the medium. This medium is incubated for a maximum of 5 days. After incubation, if the detection of microbes is confirmed by visual turbidity and the test is repeated for a panel of Gram-negative organisms, Gram-positive organisms, molds, and yeasts, the suitability test will detect these organisms if they are present in the product during routine testing of a batch. However, the USP 71 test requires an incubation period of 14 days.

Pharmacopoeias worldwide use available data to determine the 14-day sterility threshold. Available data support the efficacy of the 14-day sterility method in recovering a variety of organisms:

• Pathogenic organisms of urgent health concern (E. coli, S. aureus)
• Stressful environmental isolates likely to arise during production (molds such as Penicillium and spore-formers such as Bacillus)
• Slow-growing organisms that can be cultured but require a full 14 days to be visually detectable (most notably, C. acnes)
• Organisms present at minimal levels in the sample

The USP 71 standard provides all available data for sterility testing using this traditional method, supporting the method's ability to recover these organisms. The method's compliance testing simply indicates the general problems of a given product in recovering viable microbes.

In short, the USP 71 standard is vital to the pharmaceutical and biotechnology industries because it establishes guidelines for ensuring sterile products are free of viable microorganisms. This standard is important for the following reasons:

• Patient safety: Sterility testing helps ensure that products such as injectables, surgical implants, and ophthalmic preparations are free of harmful microorganisms that can lead to infections or serious health complications.
• Regulatory Compliance: Compliance with the USP 71 standard is required by regulatory authorities such as the FDA, EMA, and other global organizations. This standard ensures that drug products meet rigorous sterility standards, making them safe for human use.
• Quality assurance: Compliance with the USP 71 standard helps manufacturers maintain a high level of quality control. By testing products for sterility, manufacturers can identify potential contamination before they reach the market, helping them maintain a reputation for producing safe and reliable products.
• Consistency and reliability: This standard provides a structured, scientifically validated method for performing sterility tests, ensuring that the tests are consistent and reliable. This is critical for products intended for use in sterile environments.
• Preventing microbial contamination: The tests outlined in the USP 71 standard help detect both microbial contamination that may occur during production and microbial contamination that may occur during storage or handling. This helps prevent microbial growth that could affect product quality and safety.

Our organization, which has been supporting businesses across all sectors for years through a wide range of testing, measurement, analysis, and evaluation activities, has a strong team of employees who closely follow global developments in science and technology and are constantly improving themselves. In this context, we also provide testing services that comply with the USP 71 Sterility Testing standard.